Bain Capital Specialty Finance
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 9 months.
- Recent price momentum is -11.9% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 1.8% of float.
- Analyst tilt is Hold.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation B
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 10.8x | Better than 76% |
| Forward P/E | 8.3x | Better than 89% |
| Price / Sales | 2.8x | Better than 45% |
| P/E vs own 5-yr range | 97th pctl | Better than 6% |
Growth C+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | -0.6% | Better than 22% |
| Net income CAGR (3Y) | -2.2% | Better than 37% |
| Free cash flow CAGR (3Y) | 34.8% | Better than 77% |
Profitability A-
How much profit the business keeps from each dollar of sales and capital.
| Net margin | 86.2% | Better than 99% |
| Return on equity | 8.8% | Better than 47% |
Momentum C
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -10.7% | Better than 49% |
| 6-month return | -15.8% | Better than 32% |
| 12-month return (ex latest month) | -17.7% | Better than 17% |
| Distance below 52-week high | 21.8% | Better than 56% |
Financial Health F
Balance-sheet strength: leverage, liquidity and interest coverage.
| Debt to assets | 55.2% | Better than 11% |
| Free cash flow / net income | 29.9% | Better than 8% |
Analyst View D
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 0.0% | Better than 0% |
| Upside to average target | 18.1% | Better than 29% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 10.44
- Open
- 10.37
- Day range
- 10.35 - 10.53
- Avg price
- 10.42
- Volume
- 585.62K
- Turnover
- 6.10M
- Turnover ratei
- 1.12%
- Volume ratioi
- 1.10
- Amplitudei
- 1.72%
- 52-week rangei
- 10.00 - 13.27
Valuation
- P/Ei
- 6.78
- P/E (TTM)i
- 10.80
- P/Bi
- 0.63
- EPSi
- 1.53
- Book value / shi
- 16.49
- Net profit
- 99.25M
- Net assets
- 1.07B
Share structure
- Market cap
- 672.69M
- Float capi
- 543.33M
- Shares out
- 64.87M
- Float sharesi
- 52.39M
Dividend & listing
- Div yield (TTM)i
- 16.20%
- Dividend (TTM)
- 1.68
- Listing date
- 2018-11-16
21.8% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-3.24M net over the window
Short interest
- Shares short
- 1.20M
- % of floati
- 1.85%
- Days to coveri
- 2.24
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Bain Capital Specialty Finance (BCSF)?
Bain Capital Specialty Finance last traded at 10.37. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Bain Capital Specialty Finance's market cap?
About 672.69M.
What is the P/E ratio of Bain Capital Specialty Finance?
The trailing twelve-month P/E is 10.80, above its own 5-year average of 8.76 — toward the top of its historical range (96.81% percentile). See the Valuation tab for the full history.
Does Bain Capital Specialty Finance pay a dividend?
Yes. The trailing dividend yield is 16.20%. The 2025 payout fell 14% from 2024 - a real reduction, not rounding noise. See the Dividends tab for the full payment history.
Is Bain Capital Specialty Finance a buy according to analysts?
The consensus of 4 analysts is a Hold rating, with an average 12-month price target of 12.25, which implies 18.1% upside from the current price. This is not investment advice.
What is Bain Capital Specialty Finance's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Bain Capital Specialty Finance a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Bain Capital Specialty Finance discussion 0 comments